High risk of hepatitis B virus reactivation among patients treated with direct-acting antivirals and coinfected with HCV and HIV - 20/03/20
Highlights |
• | HBV could be reactivated in HBcAb-positive and HBsAg-negative patients treated with direct-acting antivirals. |
• | Periodic monitoring of viral load of HBV during direct-acting antivirals treatment has been proposed in this review. |
• | HIV patients with HBcAb-positive should be treated with nucleoside/nucleotide analogous to avoid possible reactivations. |
Keywords : HBV reactivation, HIV–HCV coinfection, DAA, HCV
Plan
Vol 80 - N° 4
P. 469-496 - avril 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?